Anavex Life Sciences (AVXL) Current Assets (2011 - 2020)

Anavex Life Sciences' Current Assets history runs 10 years deep, the most recent figure standing at $31.6 million for Q2 2020.

• In Q2 2020, Current Assets rose 44.98% year-over-year to $31.6 million; the TTM figure through Jun 2020 stood at $31.6 million (up 44.98% YoY), while the FY2019 annual figure was $25.3 million, down 2.78% from the prior year.
• Current Assets came in at $31.6 million for Q2 2020 at Anavex Life Sciences, up from $25.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $31.6 million in Q2 2020 to a low of $9.4 million in Q3 2016.
• A 5-year average of $24.2 million and a median of $25.6 million in 2018 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 194.15% in 2017 and slipped 21.9% in 2018, its largest moves.
• Anavex Life Sciences' Current Assets stood at $9.4 million in 2016, then jumped by 199.5% to $28.3 million in 2017, then fell by 21.9% to $22.1 million in 2018, then rose by 14.63% to $25.3 million in 2019, then advanced by 24.88% to $31.6 million in 2020.
• According to Business Quant data, Current Assets over the past three periods registered $31.6 million, $25.3 million, and $21.8 million for Q2 2020, Q3 2019, and Q2 2019 respectively.

Peer Comparison